Clinical trials for rectal cancer
65 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Colon cancer
Rectal cancer
#NCT05706779
Adenocarcinoma
Localized
BRAF
Systemic Treatment-Naive
KRAS G12C
KRAS non G12C
NRAS
Targeted therapy
Hôpital Européen Georges Pompidou - AP-HP (Paris), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
Fédération Francophone de Cancérologie Digestive
Phase 2
Rectal cancer
#NCT05591534
Adenocarcinoma
Locally Advanced
Radiotherapy
Centre Hospitalier Universitaire de Bordeaux (Bordeaux)
CHU de Bordeaux
Phase 2
Colon cancer
Rectal cancer
#NCT05217446
Adenocarcinoma
Metastatic
BRAF
MSI/dMMR
Systemic Treatment-Naive
KRAS G12C
KRAS non G12C
MSS
NRAS
Immunotherapy
Targeted therapy
Immunotherapy
Targeted therapy
Bispecific T-cell engager antibodies
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Hôpital Européen Georges Pompidou - AP-HP (Paris), Hôpital Saint Antoine AP-HP (Paris), Institut du cancer de Montpellier (Montpellier)
Pfizer
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05118789
SCLC (Small Cell Lung Cancer)
Mesothelium
Locally Advanced
Metastatic
Metastatic Castration-resistant
ROS-1
Other mutation
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 2
Colon cancer
Rectal cancer
#NCT04730544
Locally Advanced
Metastatic
MSI/dMMR
MSS
Immunotherapy
Bispecific T-cell engager antibodies
Immunotherapy
Bispecific T-cell engager antibodies
Institut Sainte Catherine (Avignon), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre Hospitalier Universitaire de Lille (Lille) (and 9 more...)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Colon cancer
Rectal cancer
#NCT04659382
Metastatic
MSS
Systemic Treatment-Naive
MSI/dMMR
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
Fédération Francophone de Cancérologie Digestive
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04268121
Neuroendocrine tumor
Localized
CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Universitaire de Toulouse (Toulouse), CHU Amiens-Picardie (site sud) (Amiens), Centre Hospitalier Universitaire de Besançon (Besançon) (and 4 more...)
Phase 2
Colon cancer
Rectal cancer
#NCT03093116
Metastatic
NTRK-1/2/3
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Antoine Lacassagne (Nice), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers) (and 3 more...)
Turning Point Therapeutics, Inc.
Phase 2
Colon cancer
Rectal cancer
#NCT03093116
Metastatic
NTRK-1/2/3
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Targeted therapy
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Antoine Lacassagne (Nice), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers) (and 3 more...)
Turning Point Therapeutics, Inc.
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT02611024
Neuroendocrine tumor
Locally Advanced
Metastatic
Chemotherapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif)
PharmaMar